340 related articles for article (PubMed ID: 17950459)
1. The development of tolerance to drugs that suppress food intake.
Fernstrom JD; Choi S
Pharmacol Ther; 2008 Jan; 117(1):105-22. PubMed ID: 17950459
[TBL] [Abstract][Full Text] [Related]
2. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2009 Mar; 198(2):359-65. PubMed ID: 19061919
[TBL] [Abstract][Full Text] [Related]
3. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
Elfhag K; Finer N; Rössner S
Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
[TBL] [Abstract][Full Text] [Related]
4. Drug Insight: appetite suppressants.
Bray GA
Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):89-95. PubMed ID: 16265126
[TBL] [Abstract][Full Text] [Related]
5. [Comparative action of fenfluramine and amphetamine in rats with hypothalamic obesity].
Bernier A; Sicot N; Le Douarec JC
Rev Fr Etud Clin Biol; 1969 Oct; 14(8):762-72. PubMed ID: 4904574
[No Abstract] [Full Text] [Related]
6. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A
Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274
[TBL] [Abstract][Full Text] [Related]
7. Sibutramine & naloxone: infra-additive interaction in the regulation of appetite?
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2010 Feb; 207(1):174-81. PubMed ID: 19818809
[TBL] [Abstract][Full Text] [Related]
8. Tolerance and cross tolerance to the anorexigenic effect of appetite suppressants in rats.
Opitz K
Int J Obes; 1978; 2(1):59-68. PubMed ID: 711356
[TBL] [Abstract][Full Text] [Related]
9. Proteome changes in rat plasma in response to sibutramine.
Choi JW; Joo JI; Kim DH; Wang X; Oh TS; Choi DK; Yun JW
Proteomics; 2011 Apr; 11(7):1300-12. PubMed ID: 21337517
[TBL] [Abstract][Full Text] [Related]
10. Effect of isocaloric diets and sibutramine on food intake, body mass variation and serum TNF-alpha levels in rats.
Trapali M; Liapi C; Perelas A; Perrea D; Stroubini T; Dontas I; Couvari E; Mavri M; Galanopoulou P
Pharmacology; 2008; 82(1):15-21. PubMed ID: 18434760
[TBL] [Abstract][Full Text] [Related]
11. 5-HT(2C) receptor agonists and the control of appetite.
Halford JC; Harrold JA
Handb Exp Pharmacol; 2012; (209):349-56. PubMed ID: 22249823
[TBL] [Abstract][Full Text] [Related]
12. The appetite suppressant d-fenfluramine reduces water intake, but not food intake, in activity-based anorexia.
Hillebrand JJ; Heinsbroek AC; Kas MJ; Adan RA
J Mol Endocrinol; 2006 Feb; 36(1):153-62. PubMed ID: 16461935
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic agents for weight reduction.
Haller C; Schwartz JB
J Gend Specif Med; 2002; 5(5):16-21. PubMed ID: 12380196
[TBL] [Abstract][Full Text] [Related]
14. Does long-term use of sibutramine (Meridia) result in continued weight loss in short-term responders?
Stevenson JH; Trojian T; Jackson EA
J Fam Pract; 2001 Dec; 50(12):1084. PubMed ID: 11742615
[No Abstract] [Full Text] [Related]
15. Pharmacotherapy of obesity.
Linné Y; Rössner S
Clin Dermatol; 2004; 22(4):319-24. PubMed ID: 15475233
[TBL] [Abstract][Full Text] [Related]
16. Neuropharmacology of human appetite expression.
Halford JC; Harrold JA
Dev Disabil Res Rev; 2008; 14(2):158-64. PubMed ID: 18646016
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological, toxicological, deontologic, and medico-legal aspects of the use of appetite suppressant agents in "weight-loss cures"].
Carolei L; Ermio G; Accorinti N; Meo G; Lamberti V; De Sarro G
Minerva Med; 1997; 88(7-8):317-26. PubMed ID: 9304076
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of appetite suppressants.
Silverstone T
Drug Alcohol Depend; 1986 Jun; 17(2-3):151-67. PubMed ID: 3527636
[No Abstract] [Full Text] [Related]
19. [Weight reduction. Doubly effective with drug support].
MMW Fortschr Med; 2001 Apr; 143(15):42-3. PubMed ID: 11349320
[No Abstract] [Full Text] [Related]
20. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
